Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biostime Probiotics in Infants
NCT02317406Completed
- Sponsor
- Biostime
- Start
- Dec 2014
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Biostime. Primary endpoints: Proportion of Participants Achieving the modulatory effect on the GI tract flora composition at 4 weeks and Change of Lactobacillus helveticus populations in stool at 4 weeks. Started Dec 2014; status: completed.
Beyond the preview
Go deeper on NCT02317406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02317406.